Healthy volunteers help test new antifungal Drug's safety
NCT ID NCT06961708
First seen Mar 20, 2026 · Last updated May 16, 2026 · Updated 10 times
Summary
This study tested a new antifungal drug called fosmanogepix in 54 healthy Chinese adults to see how the body processes it and if it is safe. Participants received either a single dose or multiple doses of the drug or a placebo. The study did not aim to treat any disease, only to gather safety and drug-level information.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Shanghai Xuhui Central Hospital, Longchuan North Road
Shanghai, 200237, China
Conditions
Explore the condition pages connected to this study.